Chimeric Antigen Receptor T Cell Therapy and Forecast Market

List of Tables
Table 1. Chimeric Antigen Receptor T Cell Therapy Market Opportunities & Trends in Global Market
Table 2. Chimeric Antigen Receptor T Cell Therapy Market Drivers in Global Market
Table 3. Chimeric Antigen Receptor T Cell Therapy Market Restraints in Global Market
Table 4. Key Players of Chimeric Antigen Receptor T Cell Therapy in Global Market
Table 5. Top Chimeric Antigen Receptor T Cell Therapy Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Chimeric Antigen Receptor T Cell Therapy Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Chimeric Antigen Receptor T Cell Therapy Revenue Share by Companies, 2018-2023
Table 8. Global Companies Chimeric Antigen Receptor T Cell Therapy Product Type
Table 9. List of Global Tier 1 Chimeric Antigen Receptor T Cell Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Chimeric Antigen Receptor T Cell Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Chimeric Antigen Receptor T Cell Therapy Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Chimeric Antigen Receptor T Cell Therapy Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Chimeric Antigen Receptor T Cell Therapy Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Chimeric Antigen Receptor T Cell Therapy Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Chimeric Antigen Receptor T Cell Therapy Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Chimeric Antigen Receptor T Cell Therapy Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Chimeric Antigen Receptor T Cell Therapy Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Chimeric Antigen Receptor T Cell Therapy Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Chimeric Antigen Receptor T Cell Therapy Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Chimeric Antigen Receptor T Cell Therapy Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Chimeric Antigen Receptor T Cell Therapy Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Chimeric Antigen Receptor T Cell Therapy Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Chimeric Antigen Receptor T Cell Therapy Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Chimeric Antigen Receptor T Cell Therapy Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Chimeric Antigen Receptor T Cell Therapy Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Chimeric Antigen Receptor T Cell Therapy Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Chimeric Antigen Receptor T Cell Therapy Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Chimeric Antigen Receptor T Cell Therapy Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Chimeric Antigen Receptor T Cell Therapy Revenue, (US$, Mn), 2024-2029
Table 30. Amgen Company Summary
Table 31. Amgen Chimeric Antigen Receptor T Cell Therapy Product Offerings
Table 32. Amgen Chimeric Antigen Receptor T Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 33. Amgen Key News & Latest Developments
Table 34. Bellicum Pharmaceuticals Company Summary
Table 35. Bellicum Pharmaceuticals Chimeric Antigen Receptor T Cell Therapy Product Offerings
Table 36. Bellicum Pharmaceuticals Chimeric Antigen Receptor T Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 37. Bellicum Pharmaceuticals Key News & Latest Developments
Table 38. Bluebird Bio Company Summary
Table 39. Bluebird Bio Chimeric Antigen Receptor T Cell Therapy Product Offerings
Table 40. Bluebird Bio Chimeric Antigen Receptor T Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 41. Bluebird Bio Key News & Latest Developments
Table 42. Caribou Biosciences Company Summary
Table 43. Caribou Biosciences Chimeric Antigen Receptor T Cell Therapy Product Offerings
Table 44. Caribou Biosciences Chimeric Antigen Receptor T Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 45. Caribou Biosciences Key News & Latest Developments
Table 46. Celgene Corporation Company Summary
Table 47. Celgene Corporation Chimeric Antigen Receptor T Cell Therapy Product Offerings
Table 48. Celgene Corporation Chimeric Antigen Receptor T Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 49. Celgene Corporation Key News & Latest Developments
Table 50. Cellectis Company Summary
Table 51. Cellectis Chimeric Antigen Receptor T Cell Therapy Product Offerings
Table 52. Cellectis Chimeric Antigen Receptor T Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 53. Cellectis Key News & Latest Developments
Table 54. Celyad Oncology Company Summary
Table 55. Celyad Oncology Chimeric Antigen Receptor T Cell Therapy Product Offerings
Table 56. Celyad Oncology Chimeric Antigen Receptor T Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 57. Celyad Oncology Key News & Latest Developments
Table 58. Gilead Sciences Company Summary
Table 59. Gilead Sciences Chimeric Antigen Receptor T Cell Therapy Product Offerings
Table 60. Gilead Sciences Chimeric Antigen Receptor T Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 61. Gilead Sciences Key News & Latest Developments
Table 62. Intellia Therapeutics Company Summary
Table 63. Intellia Therapeutics Chimeric Antigen Receptor T Cell Therapy Product Offerings
Table 64. Intellia Therapeutics Chimeric Antigen Receptor T Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 65. Intellia Therapeutics Key News & Latest Developments
Table 66. Johnson & Johnson Company Summary
Table 67. Johnson & Johnson Chimeric Antigen Receptor T Cell Therapy Product Offerings
Table 68. Johnson & Johnson Chimeric Antigen Receptor T Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 69. Johnson & Johnson Key News & Latest Developments
Table 70. Legend Biotech Company Summary
Table 71. Legend Biotech Chimeric Antigen Receptor T Cell Therapy Product Offerings
Table 72. Legend Biotech Chimeric Antigen Receptor T Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 73. Legend Biotech Key News & Latest Developments
Table 74. Merck Company Summary
Table 75. Merck Chimeric Antigen Receptor T Cell Therapy Product Offerings
Table 76. Merck Chimeric Antigen Receptor T Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 77. Merck Key News & Latest Developments
Table 78. Noile-Immune Biotech Company Summary
Table 79. Noile-Immune Biotech Chimeric Antigen Receptor T Cell Therapy Product Offerings
Table 80. Noile-Immune Biotech Chimeric Antigen Receptor T Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 81. Noile-Immune Biotech Key News & Latest Developments
Table 82. Novartis Company Summary
Table 83. Novartis Chimeric Antigen Receptor T Cell Therapy Product Offerings
Table 84. Novartis Chimeric Antigen Receptor T Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 85. Novartis Key News & Latest Developments
Table 86. Pfizer Company Summary
Table 87. Pfizer Chimeric Antigen Receptor T Cell Therapy Product Offerings
Table 88. Pfizer Chimeric Antigen Receptor T Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 89. Pfizer Key News & Latest Developments
Table 90. Sangamo Therapeutics Company Summary
Table 91. Sangamo Therapeutics Chimeric Antigen Receptor T Cell Therapy Product Offerings
Table 92. Sangamo Therapeutics Chimeric Antigen Receptor T Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 93. Sangamo Therapeutics Key News & Latest Developments
Table 94. Servier Laboratories Company Summary
Table 95. Servier Laboratories Chimeric Antigen Receptor T Cell Therapy Product Offerings
Table 96. Servier Laboratories Chimeric Antigen Receptor T Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 97. Servier Laboratories Key News & Latest Developments
List of Figures
Figure 1. Chimeric Antigen Receptor T Cell Therapy Segment by Type in 2022
Figure 2. Chimeric Antigen Receptor T Cell Therapy Segment by Application in 2022
Figure 3. Global Chimeric Antigen Receptor T Cell Therapy Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Chimeric Antigen Receptor T Cell Therapy Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Chimeric Antigen Receptor T Cell Therapy Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Chimeric Antigen Receptor T Cell Therapy Revenue in 2022
Figure 8. By Type - Global Chimeric Antigen Receptor T Cell Therapy Revenue Market Share, 2018-2029
Figure 9. By Application - Global Chimeric Antigen Receptor T Cell Therapy Revenue Market Share, 2018-2029
Figure 10. By Type - Global Chimeric Antigen Receptor T Cell Therapy Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Chimeric Antigen Receptor T Cell Therapy Revenue Market Share, 2018-2029
Figure 12. By Application - Global Chimeric Antigen Receptor T Cell Therapy Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Chimeric Antigen Receptor T Cell Therapy Revenue Market Share, 2018-2029
Figure 14. By Region - Global Chimeric Antigen Receptor T Cell Therapy Revenue Market Share, 2018-2029
Figure 15. By Country - North America Chimeric Antigen Receptor T Cell Therapy Revenue Market Share, 2018-2029
Figure 16. US Chimeric Antigen Receptor T Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Chimeric Antigen Receptor T Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Chimeric Antigen Receptor T Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Chimeric Antigen Receptor T Cell Therapy Revenue Market Share, 2018-2029
Figure 20. Germany Chimeric Antigen Receptor T Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 21. France Chimeric Antigen Receptor T Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Chimeric Antigen Receptor T Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Chimeric Antigen Receptor T Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Chimeric Antigen Receptor T Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Chimeric Antigen Receptor T Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Chimeric Antigen Receptor T Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Chimeric Antigen Receptor T Cell Therapy Revenue Market Share, 2018-2029
Figure 28. China Chimeric Antigen Receptor T Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Chimeric Antigen Receptor T Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Chimeric Antigen Receptor T Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Chimeric Antigen Receptor T Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 32. India Chimeric Antigen Receptor T Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Chimeric Antigen Receptor T Cell Therapy Revenue Market Share, 2018-2029
Figure 34. Brazil Chimeric Antigen Receptor T Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Chimeric Antigen Receptor T Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Chimeric Antigen Receptor T Cell Therapy Revenue Market Share, 2018-2029
Figure 37. Turkey Chimeric Antigen Receptor T Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Chimeric Antigen Receptor T Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Chimeric Antigen Receptor T Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Chimeric Antigen Receptor T Cell Therapy Revenue, (US$, Mn), 2018-2029
Figure 41. Amgen Chimeric Antigen Receptor T Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Bellicum Pharmaceuticals Chimeric Antigen Receptor T Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Bluebird Bio Chimeric Antigen Receptor T Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Caribou Biosciences Chimeric Antigen Receptor T Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Celgene Corporation Chimeric Antigen Receptor T Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Cellectis Chimeric Antigen Receptor T Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Celyad Oncology Chimeric Antigen Receptor T Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Gilead Sciences Chimeric Antigen Receptor T Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Intellia Therapeutics Chimeric Antigen Receptor T Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Johnson & Johnson Chimeric Antigen Receptor T Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Legend Biotech Chimeric Antigen Receptor T Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Merck Chimeric Antigen Receptor T Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Noile-Immune Biotech Chimeric Antigen Receptor T Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Novartis Chimeric Antigen Receptor T Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Pfizer Chimeric Antigen Receptor T Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. Sangamo Therapeutics Chimeric Antigen Receptor T Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 57. Servier Laboratories Chimeric Antigen Receptor T Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)